Novel Processes For The Production Of Oligonucleotides

Patent No. EP3481838 (titled "Novel Processes For The Production Of Oligonucleotides") was filed by Glaxosmithkline on Jul 7, 2017. The application was issued on Aug 19, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
JANSSEN PHARMACEUTICAMay 19, 2021KILBURN & STRODE
JG OPPOSITIONSMay 19, 2021FORD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3481838

GLAXOSMITHKLINE
Application Number
EP17739936A
Filing Date
Jul 7, 2017
Status
Revoked
Jul 1, 2025
Publication Date
Aug 19, 2020